StockNews.com started coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Free Report) in a report released on Wednesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Separately, Maxim Group restated a hold rating on shares of Agile Therapeutics in a research report on Monday, March 18th. Read Our Latest Stock […]